LIVAZO Trademark

Trademark Overview

On Thursday, September 30, 2021, a trademark application was filed for LIVAZO with the United States Patent and Trademark Office. The USPTO has given the LIVAZO trademark a serial number of 79326263. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 26, 2023. This trademark is owned by KOWA COMPANY, LTD. The LIVAZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of conditions and diseases of the circulatory system
livazo

General Information

Serial Number79326263
Word MarkLIVAZO
Filing DateThursday, September 30, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, January 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of conditions and diseases of the circulatory system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKOWA COMPANY, LTD
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Monday, February 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 26, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 26, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 9, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, April 10, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 26, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, January 26, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, January 26, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 20, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 8, 2022REFUSAL PROCESSED BY IB
Thursday, July 14, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 14, 2022REFUSAL PROCESSED BY MPU
Saturday, July 2, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 1, 2022NON-FINAL ACTION WRITTEN
Friday, July 1, 2022ASSIGNED TO EXAMINER
Friday, December 10, 2021APPLICATION FILING RECEIPT MAILED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 4, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 18, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

livazo circulatory system diseases conditions preparations treatment pharmaceutical